The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this method offers a more convenient way to administer https://tegangubr147021.myparisblog.com/41521600/glp-1-patches-a-novel-approach-to-diabetes-management